SOPH 13F position history: Chuck Akre - Akre Capital Management
SOPHiA GENETICS SA, as reported in Chuck Akre - Akre Capital Management’s quarterly 13F filings. See all fund managers holding SOPH.
| Quarter | Activity | Shares | Value | % of portfolio | Reported price | |
|---|---|---|---|---|---|---|
| Q2 2026 | No change | 3,719,140 | $21,459,438 | 0.42% | $5.77 | Filing |
| Q1 2026 | No change | 3,719,140 | $18,409,743 | 0.30% | $4.95 | Filing |
| Q4 2025 | No change | 3,719,140 | $17,368,384 | 0.19% | $4.67 | Filing |
| Q3 2025 | No change | 3,719,140 | $17,703,106 | 0.18% | $4.76 | Filing |
| Q2 2025 | Added | 3,719,140 | $11,529,334 | 0.11% | $3.10 | Filing |
| Q1 2025 | No change | 2,237,504 | $7,428,513 | 0.07% | $3.32 | Filing |
| Q4 2024 | No change | 2,237,504 | $6,869,137 | 0.06% | $3.07 | Filing |
| Q3 2024 | Added | 2,237,504 | $8,166,890 | 0.07% | $3.65 | Filing |
| Q2 2024 | Added | 1,920,432 | $8,795,579 | 0.08% | $4.58 | Filing |
| Q1 2024 | New | 287,699 | $1,418,356 | 0.01% | $4.93 | Filing |